Imugene Limited Stock OTC Markets
Stocks
IUGNF
AU000000IMU9
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
10:23:02 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.0640 USD | -14.21% |
|
-15.18% | -75.38% |
| Market Cap | 34.28M 24.59M 21.19M 19.87M 18.14M 34.17M 2.35B 236M 91.98M 1.19B 92.34M 90.33M 3.93B | P/E 2027 * |
-0.89x | P/E 2028 * | -1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 33.28M 23.88M 20.58M 19.29M 17.61M 33.17M 2.28B 229M 89.3M 1.15B 89.65M 87.7M 3.82B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
96.9% | Yield 2027 * |
-
| Yield 2028 * | - |
| 1 day | -14.21% | ||
| 1 week | -15.18% | ||
| Current month | -1.54% | ||
| 1 month | -36.00% | ||
| 3 months | -20.00% | ||
| 6 months | -64.64% | ||
| Current year | -75.38% |
| 1 week | 0.05 |  | 0.1 |
| 1 month | 0.04 | | 0.1 |
| Current year | 0.04 | | 0.3 |
| 1 year | 0.04 | | 0.31 |
| 3 years | 0.04 | | 3.57 |
| 5 years | 0.04 | | 15.95 |
| 10 years | 0.04 | | 15.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Darren Keamy
DFI | Director of Finance/CFO | - | 2025-03-03 |
John Byon
CTO | Chief Tech/Sci/R&D Officer | - | 2023-08-31 |
Ursula McCurry
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Hopper
CHM | Chairman | 70 | 2012-10-30 |
Lesley Russell
BRD | Director/Board Member | 66 | 2019-04-22 |
Jakob Dupont
BRD | Director/Board Member | 61 | 2022-09-06 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -14.21% | -15.18% | - | - | 24.59M | |
| -0.78% | -1.42% | +2.96% | +21.65% | 50.47B | |
| -6.00% | -0.75% | +447.48% | +535.14% | 44.56B | |
| -0.24% | +0.74% | +37.18% | +16.26% | 43.08B | |
| -1.55% | -2.07% | +19.83% | +71.70% | 41.7B | |
| -0.31% | -0.83% | +19.47% | +48.24% | 33.21B | |
| -1.79% | -3.24% | +26.32% | +125.06% | 16.77B | |
| -0.58% | -2.12% | - | - | 16.28B | |
| -0.88% | -0.66% | +11.63% | +27.62% | 14.58B | |
| -1.66% | -1.25% | +78.49% | +42.97% | 13.92B | |
| Average | -2.80% | -1.06% | +80.42% | +111.08% | 30.51B | |
| Weighted average by Cap. | -1.70% | -1.06% | +96.28% | +129.03% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -42.79M -30.7M -26.45M -24.8M -22.64M -42.65M -2.93B -294M -115M -1.48B -115M -113M -4.91B | -33.44M -23.99M -20.67M -19.38M -17.7M -33.34M -2.29B -230M -89.73M -1.16B -90.08M -88.12M -3.84B |
| Net Debt | -1M -717K -618K -580K -529K -997K -68.57M -6.88M -2.68M -34.61M -2.69M -2.64M -115M | -5.2M -3.73M -3.21M -3.01M -2.75M -5.18M -357M -35.76M -13.95M -180M -14.01M -13.7M -597M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | US$0.0640 | -14.21% | 45,000 |
| 26-08-27 | US$0.0746 | -17.11% | 53,968 |
| 26-08-25 | US$0.0900 | -6.83% | 20,002 |
| 26-08-24 | US$0.0966 | +28.03% | 1,008 |
| 26-08-21 | US$0.0755 | -15.70% | 15,925 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMU Stock
- IUGNF Stock
Select your edition
All financial news and data tailored to specific country editions
